Zhejiang Shouxiangu Pharm Co Financial Flexibility Index
Zhejiang Shouxiangu Pharm Co financial flexibility index. Zhejiang Shouxiangu Pharm Co (603896) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥81.32 Million (operating CF CN¥20.94 Million minus capex CN¥60.38 Million) represents 0% of total liabilities (CN¥841.89 Million). See free cash flow generation of Zhejiang Shouxiangu Pharm Co to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Shouxiangu Pharm Co (2012–2025)
Financial flexibility index of Zhejiang Shouxiangu Pharm Co from 2012 to 2025. Historical Financial Flexibility Index trend for Zhejiang Shouxiangu Pharm Co across 14 annual periods. Check Zhejiang Shouxiangu Pharm Co (603896) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Shouxiangu Pharm Co Financial Flexibility Index by Year (2012–2025)
Zhejiang Shouxiangu Pharm Co financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Shouxiangu Pharm Co. For the full cash flow conversion analysis, see 603896 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥501.29 Million | CN¥228.07 Million | CN¥1.02 Billion | ▼ -43.0% |
| 2024 | 0.86x | CN¥720.50 Million | CN¥213.44 Million | CN¥837.17 Million | ▲ +18.3% |
| 2023 | 0.73x | CN¥729.60 Million | CN¥315.06 Million | CN¥1.00 Billion | ▲ +32.0% |
| 2022 | 0.55x | CN¥523.88 Million | CN¥341.28 Million | CN¥950.67 Million | ▼ -58.8% |
| 2021 | 1.34x | CN¥458.32 Million | CN¥296.70 Million | CN¥342.41 Million | ▲ +55.5% |
| 2020 | 0.86x | CN¥321.34 Million | CN¥256.36 Million | CN¥373.28 Million | ▼ -51.6% |
| 2019 | 1.78x | CN¥299.40 Million | CN¥207.92 Million | CN¥168.31 Million | ▼ -9.0% |
| 2018 | 1.96x | CN¥404.36 Million | CN¥171.51 Million | CN¥206.79 Million | ▼ -22.2% |
| 2017 | 2.51x | CN¥142.25 Million | CN¥110.80 Million | CN¥56.60 Million | ▲ +224.3% |
| 2016 | 0.78x | CN¥135.77 Million | CN¥95.52 Million | CN¥175.17 Million | ▼ -14.8% |
| 2015 | 0.91x | CN¥215.90 Million | CN¥85.03 Million | CN¥237.38 Million | ▼ -31.4% |
| 2014 | 1.33x | CN¥239.07 Million | CN¥102.90 Million | CN¥180.43 Million | ▼ -18.8% |
| 2013 | 1.63x | CN¥179.32 Million | CN¥65.85 Million | CN¥109.85 Million | ▲ +136.4% |
| 2012 | 0.69x | CN¥93.66 Million | CN¥45.36 Million | CN¥135.64 Million | — |